Concepedia

Paul Miller

PM

9

Publications

1.1K

Citations

9

H-Index

1997

Active since

Affiliations

Pfizer (United Kingdom)(Current)

King's College Hospital

Pfizer (France)

Pfizer (United States)

Paul Miller is an author at Pfizer (United Kingdom) specializing in law, bioethics, and end-of-life care.

Top concepts

Publications per year

1997–2017

9

Publications

9

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

Franco M. Muggia, John D. Hainsworth, Susan Jeffers et al. · Journal of Clinical Oncology · 1997 · 656 citations

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation

David I. Marks, Antonio Pagliuca, Christopher C. Kibbler et al. · British Journal of Haematology · 2011 · 242 citations · Full text

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results

Eileen M. O’Reilly, James Roach, Paul Miller et al. · The Oncologist · 2017 · 44 citations · Full text

Plasma Pharmacokinetics of Two Consecutive Doses of Ferumoxytol in Healthy Subjects

Amy Barton Pai, Jace Nielsen, Annamaria Kausz et al. · Clinical Pharmacology & Therapeutics · 2010 · 33 citations

Life after Death with Dignity: The Oregon Experience

Paul Miller · Social Work · 2000 · 21 citations

, , +17

Rows per page

1–5 of 9